HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Management of chronic or intermittent primary angle-closure glaucoma: a long-term follow-up of the results of peripheral iridectomy used as an initial procedure.

Abstract
Patients presenting with either intermittent closed-angle glaucoma which gave to subacute congestive attacks or with chronic angle-closure glaucoma were followed up over 12 years. Peripheral iridectomy was performed as a primary procedure on these patients during this period. It was found to be a highly effective procedure in those patients without field loss at the time of presentation, but because of the figures presented here we would recommend that any patient presenting with angle closure and disc and field changes should have a trabeculectomy performed as a primary procedure. We found no way of predicting which patients would require further surgery from the history, initial intraocular pressure, or the gonioscopic findings. No patient in this series developed malignant glaucoma after trabeculectomy although it occurred in 2 eyes after peripheral iridectomy.
AuthorsT J Playfair, P G Watson
JournalThe British journal of ophthalmology (Br J Ophthalmol) Vol. 63 Issue 1 Pg. 23-8 (Jan 1979) ISSN: 0007-1161 [Print] England
PMID760772 (Publication Type: Comparative Study, Journal Article)
Chemical References
  • Miotics
Topics
  • Adult
  • Aged
  • Chronic Disease
  • Female
  • Follow-Up Studies
  • Glaucoma (physiopathology, surgery)
  • Humans
  • Intraocular Pressure
  • Iris (surgery)
  • Male
  • Middle Aged
  • Miotics (therapeutic use)
  • Postoperative Complications (epidemiology, surgery)
  • Time Factors
  • Trabecular Meshwork (surgery)
  • Visual Fields

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: